Nails in osteoporosis and bone metabolism: a narrative review of current evidence and future directions

Beyond the T-Score: A Narrative Clinical Review of Adult Endocrine Osteoporosis Care

Background/Objectives: Bone mineral density (BMD) is fundamental to osteoporosis assessment, but fracture risk is also shaped by fracture history, falls, frailty, secondary causes, age, sex, and treatment context. This narrative review examines clinically relevant information that modifies adult endocrine decision-maki...

Osteoporosis Diagnosis and Management: A Review from an Orthopedic Perspective

This review synthesizes international guidelines and recent literature to provide a practical framework for DEXA interpretation, laboratory integration, and holistic management aimed at reducing refracture risk, improving functional outcomes, and lowering healthcare costs.

Male osteoporosis: pathophysiology, risk assessment, and evidence-based management

Effective care in cases of male osteoporosis requires an integrated risk-based approach that extends beyond BMD to include clinical risk factors, secondary causes, and functional status, and improved recognition and sex-specific management strategies are essential to reduce the fracture burden and improve long-term out...

Prevalence of osteoporosis and low bone mass in men with prostate cancer: a systematic review and meta-analysis

Bone mineral density and trabecular bone score in adults with primary immunodeficiencies: a cross-sectional study

Assessment of bone mineral density (BMD), trabecular bone score (TBS), and muscle mass in adults with PIDs found reduced BMD and impaired TBS represented distinct, partially overlapping findings.

Clinical and Laboratory Predictors of Bone Mineral Density Trajectories and Osteoporosis Progression: A Retrospective Longitudinal Cohort Study

No routinely measured biomarker demonstrated clinical utility for identifying BMD trajectory in this cohort of Saudi dual-energy X-ray absorptiometry patients, suggesting future studies with explicit treatment tracking and repeated bone-turnover measurements are required for confirmation.